Larimar Therapeutics Announces Three Poster Presentations at the 2024 International Congress for Ataxia Research (ICAR) on November 12–15, 2024 Larimar will present three posters during the conference, one of which will also be presented as an oral presentation. The poster presentations are as follows:
- Effect of nomlabofusp administration on tissue frataxin levels, plasma lipid profiles, and gene expression in patients with Friedreich’s ataxia
- Disease characteristics and tissue frataxin concentrations in adults with Friedreich’s ataxia participating in nomlabofusp interventional studies
- Prediction of tissue frataxin levels with long-term administration of nomlabofusp in adults with Friedreich’s ataxia using modeling and simulations.